[Treatment of cardiogenic shock with percutanous mechanical circulatory support].
Despite rapid revascularisation with circulatory support using inotropes and intra-aortic balloon counterpulsation, the mortality of cardiogenic shock complicating acute myocardial infarction still exceeds 50%. An alternative treatment strategy is restoration of cardiac output by using a ventricular assist device which can be inserted in the acute setting using the Impella device, a catheter-based flow pump. DanShock is a Danish multicentre study that will assess whether circulatory support using the Impella device will improve the outcome of cardiogenic shock compared to conventional management.
D002302:Cardiac Output / Q000502:physiology; D003718:Denmark; D005471:Fluoroscopy; D006353:Heart-Assist Devices; D006801:Humans; D011474:Prosthesis Design; D012770:Shock, Cardiogenic / Q000401:mortality / Q000628:therapy*; D016896:Treatment Outcome; D016277:Ventricular Function, Left